Iranian gamma probes enable over 2,000 surgeries
A knowledge-based company in Iran has designed a surgical assistance system to detect areas with high radiopharmaceutical uptake in the body, aiming to prevent capital outflow and achieve advanced technologies to meet national needs, improve patient health, and enhance quality of life.
According to the Communication and Information Center of the Iranian Vice Presidency for Science, Technology, and Knowledge-Based Economy, Parto Negar Persia imaging industries development company focuses on producing diagnostic, therapeutic, and research medical equipment.
The company aims to reduce dependency on foreign countries and enhance the scientific capabilities of Iranian specialists by leveraging the creativity, scientific knowledge, and technical skills of local experts and young, dedicated scientific personnel.
Mohammadreza Ay, CEO of Parto Negar Persia, described the GammaPen system as a surgical aid used to detect areas with high radiopharmaceutical uptake in the body or tissue.
The GammaPen system is used to identify and locate radiopharmaceuticals previously injected and distributed in the body, he explained.
Commonly used radiopharmaceuticals include Tc-99m, I-131, and F-18, but Gamma probes can be utilized in open surgeries, laparoscopies, and thoracoscopies, as well as externally.
Ay noted that gamma probes are beneficial in detecting small areas with high activity distribution, sensitivity, and resolution. He highlighted that over 113 Iranian hospitals use this knowledge-based product, which is competitive with foreign counterparts in terms of quality and quantity. To date, more than 2,000 surgeries have been performed using gamma probes.
